Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.
about
Effects of aging and exercise training on apoptosis in the heartSaffron as an antidote or a protective agent against natural or chemical toxicitiesA review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proofTreatment of intermediate stage hepatocellular carcinoma: a review of intrahepatic doxorubicin drug-delivery systemsTargeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model.From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials.Targeted Delivery of Proteasome Inhibitors to Somatostatin-Receptor-Expressing Cancer Cells by Octreotide ConjugationAptamer-Mediated Targeted Delivery of Therapeutics: An UpdateCombination treatment including targeted therapy for advanced hepatocellular carcinomaChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsROCK1 deficiency enhances protective effects of antioxidants against apoptosis and cell detachmentDissecting the Mechanisms of Doxorubicin and Oxidative Stress-Induced Cytotoxicity: The Involvement of Actin Cytoskeleton and ROCK1Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional ChemotherapeuticsNanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitorsNew Metabolites and Bioactive Actinomycins from Marine-Derived Streptomyces sp. ZZ338Second-generation probes for biosynthetic intermediate capture: towards a comprehensive profiling of polyketide assemblyLiposome-Cross-Linked Hybrid Hydrogels for Glutathione-Triggered Delivery of Multiple Cargo MoleculesIn vitro and in vivo imaging of peptide-encapsulated polymer nanoparticles for cancer biomarker activated drug deliverySpirotetronate polyketides as leads in drug discovery.Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells.The minipig as a new model for the evaluation of doxorubicin-induced chronic toxicity.Blocking Interleukin-4 Receptor α Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell ProliferationFabrication, characterization, and biological evaluation of anti-HER2 indocyanine green-doxorubicin-encapsulated PEG-b-PLGA copolymeric nanoparticles for targeted photochemotherapy of breast cancer cellsAnticancer potential of Thevetia peruviana fruit methanolic extract.Rare Polyene-polyol Macrolides from Mangrove-derived Streptomyces sp. ZQ4BG.Synthesis, characterization, and biological verification of anti-HER2 indocyanine green-doxorubicin-loaded polyethyleneimine-coated perfluorocarbon double nanoemulsions for targeted photochemotherapy of breast cancer cellsEffect of the piperazine unit and metal-binding site position on the solubility and anti-proliferative activity of ruthenium(II)- and osmium(II)- arene complexes of isomeric indolo[3,2-c]quinoline-piperazine hybrids.A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast CancerEffects of PPARα/PGC-1α on the myocardial energy metabolism during heart failure in the doxorubicin induced dilated cardiomyopathy in miceComplex changes in the apoptotic and cell differentiation programs during initiation of the hair follicle response to chemotherapyRho-Associated Kinase Inhibitor (Y-27632) Attenuates Doxorubicin-Induced Apoptosis of Human Cardiac Stem CellsDoxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro.Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineAn improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistanceMagnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarkerCellular interactions of doxorubicin-loaded DNA-modified halloysite nanotubes.Fitness profiling links topoisomerase II regulation of centromeric integrity to doxorubicin resistance in fission yeastMulti-functional self-fluorescent unimolecular micelles for tumor-targeted drug delivery and bioimaging.miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.Assessing chemical constituents of Mimosa caesalpiniifolia stem bark: possible bioactive components accountable for the cytotoxic effect of M. caesalpiniifolia on human tumour cell lines.
P2860
Q26823797-5D1AD9A0-D061-4049-ACC8-15094924CC18Q27021426-777C5F83-6645-4C46-82C2-3A77CD98A48BQ27022812-304FAB61-DC97-4779-AF47-C1A65295E1EEQ27025606-2DEA8269-6A7C-4ABB-BD3D-7BDA81CBE42BQ27316967-8F6110B7-164E-416F-BC7D-2991CA13687DQ27687259-01ADBDA8-3690-4A75-8C10-0094AC38A68FQ27702302-1D0C0356-9114-4E26-BFF7-B2E3CF7A5B0DQ28066827-40B34EC8-557E-4637-BFED-5CD2C0826D2CQ28077738-8DD9A95B-E827-4676-AC43-590AB4366545Q28079705-82DA04FE-B1C4-4C28-819D-9FFFFFB93B76Q28540406-B3D6977A-2A60-4F25-8882-D313E00EE601Q28546141-93C66375-AE45-4317-94E1-E9FF86CA46BDQ28548620-8F4A4884-B948-4BDA-A296-ED91775ECF9CQ28818166-8CF6AB8F-B59C-4D4A-9EEF-B0861193D2BBQ28820957-AB518958-7568-4540-9EC7-B830F1258018Q28822516-9ABAE3C3-AF01-481C-9C09-8562B085D9A7Q28829477-0E05D4BF-18CF-4203-91C0-06CAF85CF0CCQ30423979-2429AE27-EA31-4B74-B94E-5F99364FDB34Q30872494-E16E7C92-81C3-4744-9145-5F28C2196413Q32178363-121F0A97-78B9-4347-B894-B30ED5F8A205Q33427938-81B1BA56-24BE-4863-BA2C-49563A5B7A0DQ33584148-99378D8D-3E85-47A9-9332-4F9E1025D27AQ33587331-3894E0E7-4367-420E-BCD1-B44BB4620379Q33630033-64B4ECBB-E524-4286-B05C-84AA6588FCC8Q33687163-C4456D2E-68C1-4E4E-95B2-5CC0BC2F98E7Q33706296-33AD65D3-D89E-47CE-86B7-1D51D63B194AQ33864513-CFE364D5-7D5E-4EEE-974C-A0DE5FEF8138Q33916210-ADADD66D-38DD-46BE-81FC-EF871D3172F6Q34414867-E6C88D63-C6EF-4676-A6EC-59634A05B04BQ34490533-2C42585C-C9DB-4B8A-A2A2-9CB712BF8AB7Q34504392-C388AD13-C9D5-40C5-A55B-131A93424899Q34653188-8D1F105C-D9A8-4B24-A76D-7F38DF4DF67EQ34698624-68759C31-17EC-486F-9681-FB20E24A4C74Q34714270-DD3E4964-1A97-47D6-826E-D81B5FA89151Q34783695-82836D98-A6D6-42BC-8FB1-1F528127D3E5Q34870807-5B4FEAEE-BCE5-4EFB-AA1B-150755BAE6FDQ35070152-3FD59417-6065-4115-A431-FB7FBF9D825BQ35086529-C165A4B0-FAD9-43F5-B7E3-555E57CE26C1Q35291824-C90D2166-AA6D-4A9D-832F-B415C090E2E5Q35573697-2615F194-CAE6-491F-926D-C219D7673B55
P2860
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Doxorubicin: an update on anti ...... d novel drug delivery systems.
@ast
Doxorubicin: an update on anti ...... d novel drug delivery systems.
@en
Doxorubicin: an update on anti ...... d novel drug delivery systems.
@nl
type
label
Doxorubicin: an update on anti ...... d novel drug delivery systems.
@ast
Doxorubicin: an update on anti ...... d novel drug delivery systems.
@en
Doxorubicin: an update on anti ...... d novel drug delivery systems.
@nl
prefLabel
Doxorubicin: an update on anti ...... d novel drug delivery systems.
@ast
Doxorubicin: an update on anti ...... d novel drug delivery systems.
@en
Doxorubicin: an update on anti ...... d novel drug delivery systems.
@nl
P1476
Doxorubicin: an update on anti ...... nd novel drug delivery systems
@en
P2093
Crispin R Dass
Oktay Tacar
P304
P356
10.1111/J.2042-7158.2012.01567.X
P577
2012-08-02T00:00:00Z